[Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
Sapary
L
L
Horvath
B
B
Alexy
T
T
Marton
Zs
Z
Kesmarky
G
G
Zsots
M
M
Nagy
F
F
Czopf
I
I
Toth
K
K
D001809:Blood Viscosity / Q000187:drug effects*; D002560:Cerebrovascular Circulation / Q000187:drug effects / Q000502:physiology; D002561:Cerebrovascular Disorders / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D002908:Chronic Disease; D004903:Erythrocyte Aggregation / Q000187:drug effects*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005500:Follow-Up Studies; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014748:Vinca Alkaloids / Q000008:administration & dosage / Q000627:therapeutic use*
D018696:Neuroprotective Agents; D014748:Vinca Alkaloids; C013983:vinpocetine; D005340:Fibrinogen